Tryptamine-Based SHIP Inhibitors for the Treatment of Cancer

John Chisholm (Inventor), Sandra Fernandes (Inventor), William Kerr (Inventor)

Research output: Patent


The present disclosure provides compositions that inhibit the SH2-containing inositol 5′-phosphatase (SHIP), as well as methods using such compositions for use in treating or ameliorating the effects of a medical condition in a subject.
Original languageEnglish (US)
Patent number10,736,877
Priority date12/31/15
Filing date12/30/16
StateAccepted/In press - Jul 6 2017


Dive into the research topics of 'Tryptamine-Based SHIP Inhibitors for the Treatment of Cancer'. Together they form a unique fingerprint.

Cite this